OSCR

Targeting m<sup>6</sup>A writer METTL3 with engineered nanovesicles reduces neuroinflammation in vitro and in vivo.

Code ↔ Paper

5 matches between paragraphs of the paper and lines of its authors' code, computed by the harvester (lexical-v1). Click a colored paragraph or line to see its counterpart.

4 blocks of code here have a permanent identifier (oscr:b:…), listed with the matches below: citable for good, with a page of its own. Select a match and press Cite to copy it. What a block identifier is.

The 5 matches · 1 of them tie a paragraph to a whole file without given lines: a weak match, whose lines are not tinted
  1. [1] § Results › METTL3 knockdown inhibits the JAK2/STAT3 pathway through the m6A-SOCS3 axis in neuroinflammation ↔ R/01_merip_exomePeak2_from_bam.R, lines 21 to 108 · score 0.70 · METTL3 KO, m6A peaks, MeRIP, WT, hypomethylated, GSE264486 · block oscr:b:YVYER37XNN4B3-F · Report a mismatch
  2. [2] § Methods › Bioinformatics analysis ↔ R/01_merip_exomePeak2_from_bam.R, lines 21 to 108 · score 0.65 · Peak calling, exomePeak2, mm10, GSE264486, BAM, seq · block oscr:b:YVYER37XNN4B3-F · Report a mismatch
  3. [3] § Methods › RNA-seq assay and data analysis ↔ R/10_bulk_rnaseq_edgeR_limma.R, lines 65 to 100 · score 0.60 · RNA seq, fold change, KEGG, log2, GSEA, enrichment · block oscr:b:FTYFMRHEXDATE-7 · Report a mismatch
  4. [4] § Methods › Statistics and reproducibility ↔ R/10_bulk_rnaseq_edgeR_limma.R, lines 1 to 63 · score 0.55 · limma voom, Bayes · block oscr:b:958JD6D40YDFJ-N · Report a mismatch
  5. [5] § Results › METTL3 knockdown inhibits the JAK2/STAT3 pathway through the m6A-SOCS3 axis in neuroinflammation ↔ R/02_merip_precomputed_peak_downstream.R, the whole file · a weak match · score 0.52 · METTL3 KO, peaks, WT, overlap, hypomethylated, GSE264486 · block oscr:b:B3Y117D86JA0S-U · Report a mismatch

Paper

Loaded from Europe PMC by your browser; OSCR does not store it: doi.org · Europe PMC

The paper is loaded when this pane is shown.

The authors' code

R · 108 lines · 5.2 KB · no license · 2 matches

  1. #!/usr/bin/env Rscript
  2. suppressPackageStartupMessages({
  3. library(data.table)
  4. library(dplyr)
  5. library(exomePeak2)
  6. library(TxDb.Mmusculus.UCSC.mm10.knownGene)
  7. library(BSgenome.Mmusculus.UCSC.mm10)
  8. })
  9. source("R/functions_enrichment_plot.R")
  10. make_dir("output/exomePeak2")
  11. make_dir("output/tables")
  12. make_dir("output/plots")
  13. meta <- fread("config/sample_info.csv")
  14. meta[, bam := file.path("bam", paste0(srr, "_sorted.bam"))]
  15. missing_bam <- meta[!file.exists(bam), bam]
  16. if (length(missing_bam) > 0) stop("Missing BAM files:\n", paste(missing_bam, collapse = "\n"))
  17. get_bams <- function(condition, assay) meta[condition == !!condition & assay == !!assay][order(replicate), bam]
  18. # data.table-safe selection
  19. wt_ip <- meta[condition == "WT" & assay == "IP"][order(replicate), bam]
  20. wt_input <- meta[condition == "WT" & assay == "Input"][order(replicate), bam]
  21. ko_ip <- meta[condition == "KO" & assay == "IP"][order(replicate), bam]
  22. ko_input <- meta[condition == "KO" & assay == "Input"][order(replicate), bam]
  23. cat("WT IP BAMs:\n", paste(wt_ip, collapse = "\n"), "\n")
  24. cat("WT Input BAMs:\n", paste(wt_input, collapse = "\n"), "\n")
  25. cat("KO IP BAMs:\n", paste(ko_ip, collapse = "\n"), "\n")
  26. cat("KO Input BAMs:\n", paste(ko_input, collapse = "\n"), "\n")
  27. # exomePeak2 differential mode: WT is control; KO is treated.
  28. # If library strandness is known, change library_type to "1st_strand" or "2nd_strand".
  29. sep <- exomePeak2(
  30. bam_ip = wt_ip,
  31. bam_input = wt_input,
  32. bam_treated_ip = ko_ip,
  33. bam_treated_input = ko_input,
  34. txdb = TxDb.Mmusculus.UCSC.mm10.knownGene,
  35. bsgenome = BSgenome.Mmusculus.UCSC.mm10,
  36. paired_end = FALSE,
  37. library_type = "unstranded",
  38. fragment_length = 100,
  39. glm_type = "DESeq2",
  40. LFC_shrinkage = "none",
  41. parallel = FALSE,
  42. export_results = TRUE,
  43. export_format = c("CSV", "BED", "RDS"),
  44. table_style = "bed",
  45. save_plot_GC = TRUE,
  46. save_plot_analysis = TRUE,
  47. save_plot_name = "GSE264486_Mettl3KO_vs_WT_LPS",
  48. save_dir = "output/exomePeak2",
  49. peak_calling_mode = "exon"
  50. )
  51. saveRDS(sep, "output/exomePeak2/exomePeak2_object.rds")
  52. # Locate exported exomePeak2 CSV. Different versions may name it slightly differently.
  53. csvs <- list.files("output/exomePeak2", pattern = "\\.csv$", recursive = TRUE, full.names = TRUE, ignore.case = TRUE)
  54. if (length(csvs) == 0) {
  55. stop("exomePeak2 finished but no CSV was found in output/exomePeak2. Check exported BED/RDS manually.")
  56. }
  57. peak_file <- csvs[which.max(file.info(csvs)$mtime)]
  58. cat("Using exported peak table: ", peak_file, "\n")
  59. peak_df <- fread(peak_file)
  60. fwrite(peak_df, "output/tables/merip_all_peaks_exomePeak2.csv")
  61. # Standard differential peak filter. Column names differ by exomePeak2 versions, so use flexible matching.
  62. cn <- colnames(peak_df)
  63. lfc_col <- cn[grepl("log2.*FC|log2.*Fold|log2FoldChange", cn, ignore.case = TRUE)][1]
  64. fdr_col <- cn[grepl("padj|fdr|adj", cn, ignore.case = TRUE)][1]
  65. gene_col <- cn[grepl("geneName|symbol|gene_name|gene", cn, ignore.case = TRUE)][1]
  66. if (is.na(lfc_col) || is.na(fdr_col)) stop("Cannot identify log2FC/FDR columns in exomePeak2 result. Please inspect output/tables/merip_all_peaks_exomePeak2.csv")
  67. peak_df[, log2FC_for_filter := as.numeric(get(lfc_col))]
  68. peak_df[, FDR_for_filter := as.numeric(get(fdr_col))]
  69. if (!is.na(gene_col)) peak_df[, geneName := as.character(get(gene_col))]
  70. hypo <- peak_df[FDR_for_filter < 0.05 & log2FC_for_filter < 0]
  71. hyper <- peak_df[FDR_for_filter < 0.05 & log2FC_for_filter > 0]
  72. fwrite(hypo, "output/tables/merip_hypomethylated_peaks.csv")
  73. fwrite(hyper, "output/tables/merip_hypermethylated_peaks.csv")
  74. cat("Hypo peaks: ", nrow(hypo), "\n")
  75. cat("Hyper peaks:", nrow(hyper), "\n")
  76. if ("Annotation" %in% colnames(peak_df)) {
  77. peak_df[, Region := standardize_region(Annotation)]
  78. hypo[, Region := standardize_region(Annotation)]
  79. hyper[, Region := standardize_region(Annotation)]
  80. fwrite(peak_df[, .N, by = Region][order(Region)], "output/tables/merip_all_region_summary.csv")
  81. fwrite(hypo[, .N, by = Region][order(Region)], "output/tables/merip_hypo_region_summary.csv")
  82. fwrite(hyper[, .N, by = Region][order(Region)], "output/tables/merip_hyper_region_summary.csv")
  83. save_region_pie(hypo, "Hypomethylated m6A peak regions", "output/plots/merip_hypo_region_pie.pdf")
  84. save_region_pie(hyper, "Hypermethylated m6A peak regions", "output/plots/merip_hyper_region_pie.pdf")
  85. reg <- rbind(data.frame(hypo[, .N, by = Region], Type = "Hypo"), data.frame(hyper[, .N, by = Region], Type = "Hyper"))
  86. if (nrow(reg) > 0) {
  87. reg <- reg %>% group_by(Type) %>% mutate(percent = N / sum(N) * 100)
  88. p <- ggplot(reg, aes(x = Region, y = percent, fill = Type)) + geom_col(position = "dodge") + theme_bw() + coord_flip() + labs(x = NULL, y = "Percentage (%)", title = "Hypo vs Hyper peak region distribution")
  89. ggsave("output/plots/merip_hypo_hyper_region_barplot.pdf", p, width = 8, height = 5)
  90. }
  91. }
  92. if ("geneName" %in% colnames(hypo)) run_enrichment(hypo$geneName, "merip_hypo", "output/tables", "output/plots")
  93. if ("geneName" %in% colnames(hyper)) run_enrichment(hyper$geneName, "merip_hyper", "output/tables", "output/plots")
  94. if ("geneName" %in% colnames(peak_df)) run_gsea(data.frame(geneName = peak_df$geneName, log2FoldChange = peak_df$log2FC_for_filter), "merip_all_peaks", "output/tables", "output/plots")
  95. cat("MeRIP-seq exomePeak2 analysis finished.\n")

01_merip_exomePeak2_from_bam.R at commit bdefa34, no license · at the source

Overview

Authors: Liangfu Xu1,2,3, Yuanwei Pan3, Guanjun Li1,2, Peng She4, Qian-Fang Meng3, Zhigang Liu1,2, Lang Rao3
ORCID iDs: Zhigang Liu, Lang Rao
  1. Cancer Center, Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People’s Hospital),Dongguan, China
  2. Shenzhen School of Clinical Medicine, Southern Medical University,Shenzhen, China
  3. Institute of Chemical Biology, Shenzhen Bay Laboratory,Shenzhen, China
  4. Department of Orthopedics, The Seventh Affiliated Hospital of Sun Yat-Sen University,Shenzhen, China
Journal: Nature communications, volume 17, issue 1, article 9534
Dates: received 24 December 2025; accepted 8 July 2026; published online 8 August 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1038/s41467-026-75862-4 · PMID 42702629 · PMCID PMC13547405 · OpenAlex W7201982615
Open access: gold, a free copy (OpenAlex)
Status: code verified (how the code is found and verified)
Categories: genetics / omics (modality), human (organism), mouse (organism), other condition (population), cellular / molecular (subfield)
Methods: Statistics
Keywords: Drug delivery, Tumour immunology
MeSH: Adenosine*, Methyltransferases*, Neuroinflammatory Diseases*, Animals, Blood-Brain Barrier, Cytokines, Disease Models, Animal, Epigenome Editing, Epitranscriptome, Female, Humans, Liposomes, Mice, Mice, Inbred C57BL, Microglia, RNA Methylation, RNA, Small Interfering (* major topic)
Topic: RNA modifications and cancer (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: National Natural Science Foundation of China (82372106 and 82222035, 82502547, 82402456)
Citations: not cited yet (Europe PMC); 68 references in the paper

Abstract

Epigenetic editing, particularly N6-methyladenosine (m6A) modification, represents a promising therapeutic strategy by silencing genes without altering DNA sequence. However, in vivo epigenetic intervention of neuroinflammation remains challenging and has rarely been explored. Here we developed a hybrid epigenetic nanomodulator, siMETTL3-hNVs, by integrating natural microglia-derived nanovesicles (NVs) with synthetic liposomes pre-loading small interfering RNA targeting the m6A writer methyltransferase-like 3 (METTL3). Natural NVs enabled siMETTL3-hNVs to achieve inflamed-brain delivery through CCR2-CCL2 chemotaxis and caveolae-mediated transcytosis across the blood-brain barrier. More importantly, relying on abundant cytokine receptors on the NVs, siMETTL3-hNVs served as decoys to neutralize pro-inflammatory cytokines, synergizing with the intracellular silencing of METTL3 to drive microglial M2 repolarization. In female mouse models of acute neuroinflammation and radiation-induced brain injury, siMETTL3-hNVs treatment significantly reduced cytokine levels, attenuated hippocampal damage, and ameliorated cognitive deficits. This work overcomes critical delivery bottlenecks in m6A-based therapeutics and establishes a robust strategy for epigenetic reprogramming of neuroinflammation.

Reproduced under the paper's license (CC BY), from the paper cited above.

Repositories

Its files are read in the Code ↔ Paper reader above, with 5 matches between paragraphs and lines of code.

Zenodo 20627531

License: CC-BY-4.0
State: the link answers, verified on 27 September 2026
Evidence: files inventoried
Size: 1 file
Software Heritage: not checked
Found in: “Code availability”
Not found: README, license file, CITATION.cff, environment file, tests, continuous integration, documentation
Tools: data.table (4 files), tidyverse (4 files), clusterProfiler (2 files), ggplot2 (2 files), edgeR (1 file), limma (1 file), pheatmap (1 file), SAMtools (1 file)
Availability: 1 check, the latest on 27 September 2026: the link answers (HTTP 200)
  • 27 September 2026: the link answers (HTTP 200)
12 files
At the source:

xulf1996-arch/mettl3_m6a_bulk_pipeline

License: none: the authors keep all their rights
State: the link answers, verified on 27 September 2026
Evidence: files inventoried
Commit: bdefa34adfeae024d569248ca75c8f0ce8c6907d, 10 June 2026
Languages: Shell (6), R (5)
Size: 17 files, 11 scripts
Software Heritage: not archived
Found in: the Zenodo archive record
Holds: README, environment (environment.yml), documentation
Not found: license file, CITATION.cff, tests, continuous integration
Tools: data.table (4 files), tidyverse (4 files), clusterProfiler (2 files), ggplot2 (2 files), edgeR (1 file), limma (1 file), pheatmap (1 file), SAMtools (1 file)
Availability: 1 check, the latest on 27 September 2026: the link answers
  • 27 September 2026: the link answers
12 files

Code availability

The R and shell scripts used for the sequencing data analysis have been deposited in Zenodo68 and are available at https://doi.org/10.5281/zenodo.20627531.

Reproduced under the paper's license (CC BY), from the paper cited above.

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 2 repositories of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 22 scripts, each with its path and the digest of its content;
  • 5 matches between paragraphs of the paper and lines of the code (method lexical-v1);
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

Datasets cited

Data availability

All data generated or analyzed during this study are available within the article, Supplementary Information, or Source Data file. The RNA-seq data generated in this study have been deposited in the Sequence Read Archive under accession number PRJNA1400104 (https://www.ncbi.nlm.nih.gov/sra?term=PRJNA1400104). The public m6A-seq dataset analyzed in this study is available from the Gene Expression Omnibus under accession number GSE264486 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264486). Source data are provided with this paper.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 7 authors, 2 keywords, 17 MeSH terms, 1 funder, 68 references.

Cite

This paper

Xu, L., Pan, Y., Li, G., She, P., Meng, Q.-F., Liu, Z., & Rao, L. (2026). Targeting m&lt;sup&gt;6&lt;/sup&gt;A writer METTL3 with engineered nanovesicles reduces neuroinflammation in vitro and in vivo. Nature communications, 17(1), 9534. https://doi.org/10.1038/s41467-026-75862-4

BibTeX

@article{xu2026targeting,
author = {Xu, Liangfu and Pan, Yuanwei and Li, Guanjun and She, Peng and Meng, Qian-Fang and Liu, Zhigang and Rao, Lang},
title = {{Targeting m\&lt;sup\&gt;6\&lt;/sup\&gt;A writer METTL3 with engineered nanovesicles reduces neuroinflammation in vitro and in vivo}},
journal = {Nature communications},
year = {2026},
month = aug,
volume = {17},
number = {1},
pages = {9534},
publisher = {Nature Publishing Group},
issn = {2041-1723},
doi = {10.1038/s41467-026-75862-4},
url = {https://doi.org/10.1038/s41467-026-75862-4},
pmid = {42702629},
pmcid = {PMC13547405}
}

RIS

TY - JOUR
AU - Xu, Liangfu
AU - Pan, Yuanwei
AU - Li, Guanjun
AU - She, Peng
AU - Meng, Qian-Fang
AU - Liu, Zhigang
AU - Rao, Lang
TI - Targeting m&lt;sup&gt;6&lt;/sup&gt;A writer METTL3 with engineered nanovesicles reduces neuroinflammation in vitro and in vivo
T2 - Nature communications
J2 - Nat Commun
PY - 2026
DA - 2026/08/08
VL - 17
IS - 1
SP - 9534
SN - 2041-1723
PB - Nature Publishing Group
DO - 10.1038/s41467-026-75862-4
UR - https://doi.org/10.1038/s41467-026-75862-4
LA - en
ER -

CSL-JSON

{
"id": "10.1038/s41467-026-75862-4",
"type": "article-journal",
"title": "Targeting m&lt;sup&gt;6&lt;/sup&gt;A writer METTL3 with engineered nanovesicles reduces neuroinflammation in vitro and in vivo",
"container-title": "Nature communications",
"author": [
{
"family": "Xu",
"given": "Liangfu"
},
{
"family": "Pan",
"given": "Yuanwei"
},
{
"family": "Li",
"given": "Guanjun"
},
{
"family": "She",
"given": "Peng"
},
{
"family": "Meng",
"given": "Qian-Fang"
},
{
"family": "Liu",
"given": "Zhigang"
},
{
"family": "Rao",
"given": "Lang"
}
],
"container-title-short": "Nat Commun",
"volume": "17",
"issue": "1",
"page": "9534",
"DOI": "10.1038/s41467-026-75862-4",
"PMID": "42702629",
"PMCID": "PMC13547405",
"ISSN": "2041-1723",
"publisher": "Nature Publishing Group",
"URL": "https://doi.org/10.1038/s41467-026-75862-4",
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
8
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3390/ijms27167275 [code]
Integrative Multi-Omics Analysis of Multiple Sclerosis Reveals Cell-Type-Specific Regulatory Landscapes and Discordant Methylation-Expression Coupling.
Journal: International journal of molecular sciences
In common: edgeR, limma, pheatmap, 3 other tools, genetics / omics, cellular / molecular, 1 reference
[2] doi:10.1038/s41586-025-09662-z [code]
Lymphoid gene expression supports neuroprotective microglia function.
Journal: Nature
In common: edgeR, pheatmap, data.table, 2 other tools, mouse, cellular / molecular, 2 references
[3] doi:10.1038/s41593-026-02384-z [code]
cGAS-mediated type I IFN signaling contributes to disease progression in drug-refractory epilepsy.
Journal: Nature neuroscience
In common: clusterProfiler, pheatmap, data.table, 2 other tools, mouse, cellular / molecular, 1 reference
[4] doi:10.1073/pnas.2404203121 [code]
Spatiotemporal transcriptomic map of glial cell response in a mouse model of acute brain ischemia.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: clusterProfiler, pheatmap, data.table, 2 other tools, genetics / omics, mouse, cellular / molecular, 1 reference
[5] doi:10.1186/s12864-025-12111-w [code]
Long-read sequencing-based analyses of the adult Drosophila brain transcriptome in physiological and pathological settings.
Journal: BMC genomics
In common: clusterProfiler, pheatmap, data.table, 2 other tools, genetics / omics, cellular / molecular, 1 reference
[6] doi:10.1371/journal.pbio.3002659 [code]
Microglial deficiency in the ATRX chromatin remodeler elicits a viral mimicry immune response that impacts neuronal function and behavior.
Journal: PLoS biology
In common: SAMtools, pheatmap, ggplot2, 1 other tool, mouse, cellular / molecular, 2 references
[7] doi:10.1038/s41514-026-00397-3 [code]
Nasal administration of Protollin enhances monocyte phagocytosis and decreases CD8&lt;sup&gt;+&lt;/sup&gt; T cell cytotoxicity in subjects with early Alzheimer's disease: a Phase 1 clinical trial.
Journal: npj aging
In common: limma, pheatmap, data.table, 2 other tools, 1 reference
[8] doi:10.1126/sciadv.abo2467 [code]
Characterization of altered molecular mechanisms in Parkinson's disease through cell type-resolved multiomics analyses.
Journal: Science advances
In common: edgeR, pheatmap, ggplot2, 1 other tool, genetics / omics, cellular / molecular, 1 reference
[9] doi:10.1016/j.isci.2024.110064 [code]
Decoding heterogeneous and coordinated tissue architecture in glioblastoma using spatial transcriptomics.
Journal: iScience
In common: limma, data.table, ggplot2, 1 other tool, genetics / omics, other condition, cellular / molecular, 1 reference
[10] doi:10.1016/j.crmeth.2025.101032 [code]
CHAS infers cell type-specific signatures in bulk brain histone acetylation studies of neurological and psychiatric disorders.
Journal: Cell reports methods
In common: edgeR, data.table, ggplot2, 1 other tool, genetics / omics, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Add the badge to the code's README

OSCR: the badge of this paper

If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.

Markdown
<!-- oscr-badge:start -->
[![OSCR](https://openscicode.org/badge/doi/10.1038/s41467-026-75862-4.svg)](https://openscicode.org/badge/doi/10.1038/s41467-026-75862-4)
<!-- oscr-badge:end -->
reStructuredText
.. oscr-badge:start

.. image:: https://openscicode.org/badge/doi/10.1038/s41467-026-75862-4.svg
   :target: https://openscicode.org/badge/doi/10.1038/s41467-026-75862-4
   :alt: OSCR

.. oscr-badge:end
HTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1038/s41467-026-75862-4"><img src="https://openscicode.org/badge/doi/10.1038/s41467-026-75862-4.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->

On GitHub, open the README, choose Edit (the pencil), paste the snippet under the title, then "Commit changes".

If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Report a mismatch between the code and the paper · Report a code error (signed in)

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Report a reproduction failure (signed in)

Versions of its code: the releases of its code tied to a version of this paper (the preprint, the accepted manuscript, the version of record…), each with the tracing map versioned with it.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.